You are here

I Radiation And Clinical Oncology Department

prof. Krzysztof Składowski, MD, PhD

Professor of Radiation Oncology, Head of 1st Radiation and Clinical Oncology Department, Regional Consultant in Radiation Oncology for Upper Silesia, President of Polish Society of Radiation Oncology, Member of ESTRO National Societies Board, International Member of ASTRO.




  • 1 titular professor of radiation oncology
  • 1 assistant professor of radiation oncology
  • 6 radiation oncology specialists
  • 2 radiation oncology trainees
  • 1 psychologist-psychotherapist
  • 17 nurses
  • 4 secretaries
  • 6 ward maids

Clinical and Scientific Profile:
  • Head and neck cancer (HNC)
  • Soft tissue and bone sarcomas (ST-BS)
  • Skin neoplasms

Diagnostic Tasks and Tools:
  • Upgrade tumour restaging before treatment decision
  • Monitor treatment tumour response and toxicity
  • Evaluate final treatment effect during follow-up
based on following technical possibilities:
  • ENT endoscopy (with specimen biopsy)
  • Ultrasound (with US guided FNA)
  • Computed Tomography (CT): standard and perfusion or dynamic contrast enhanced
  • Magnetic Resonance Imaging (MRI): standard and diffusion/perfusion and magnetization transfer and spectroscopy
  • Positron Emission Tomography with Computed Tomography (PET/CT): FDG
  • Laboratory tests oriented on:
  • HNC responsiveness – HPV, EBV
  • HNC metastatic risk – SCC, CYFRA 21.1
  • HNC hypoxia – red blood profile, osteopontin
  • General alimentation – albumin, prealbumin
  • General and radiation inflammation – ESR, CRP
  • General treatment tolerance – bone marrow, liver, kidneys, heart

Therapeutic Methods:
  1. Organ-preservation oriented, definitive accelerated fractionation radiation therapy of early advanced skin, pharynx and larynx cancer based on Intensity Modulated Radiation Therapy (IMRT), Tomotherapy™, RapidArc™ or 3D Conformal Radiation Therapy (3DCRT), all modalities guided by image set-up (IGRT).
  2. Organ-preservation oriented, concurrent radio-chemotherapy of moderate advanced pharynx and larynx cancer based on Intensity Modulated Radiation Therapy (IMRT), Tomotherapy™, RapidArc™ or 3D Conformal Radiation Therapy (3DCRT), all modalities guided by image set-up (IGRT) and combined with platinum compound or cetuximab.
  3. High Precision Hyporfactionated Radiation Therapy for:
    1. Very advanced HNC as a neoadjuvant (induction) treatment with or without systemic chemotherapy based on Tomotherapy™ or RapidArc™ and docetaxel, cisplatin and 5-Fluorouracil;
    2. Brain and body metastases based on Robotic CyberKnife™ Microradiosurgery or Microradiotherapy, Stereotactic Radiotherapy or Radiosurgery with or without GATING;
    3. HNC or ST-BS and other tumour relapses as a reirradiation based on all modalities as above.
  4. High Dose Rate (HDR) Brachytherapy for HNC, ST-BS and skin cancer as a definitive, combined boost or postoperative treatment.
  5. Postoperative radiation or chemo-radiation therapy for lip, oral cavity, maxillofacial and skin cancer, and ST-BS as an adjuvant phase of combined Head and Neck or Soft Tissue and Bone Team treatment.
  6. Systemic chemotherapy:
    1. As a concurrent, chemoradiation treatment (see p. 2);
    2. As an induction for bulky HNC as an adaptation for organ preservation treatment for HNC;
    3. Adjuvant post radiotherapy treatment for HNC and ST-BS;
    4. Palliative treatment for metastatic or recurrent tumours.
  7. Psychotherapy for depressive and painful patients over hospitalization.
  8. Hyperalimentation for body loss patients over hospitalization.
  9. Anemia treatment and prevention over and between hospitalization.
  10. Pain and anti-inflammatory treatment over and between hospitalization.

Cooperation with:
Radiation Oncology Departments in Katowice, Czestochowa, Bielsko-Biala, Opole, Wroclaw; Surgical Head and Neck and Oncology Departments in Piekary Slaskie and at Silesian Medical University.

Radiation Oncology Training:
  • CMKP courses:
    • head and neck cancer,
    • basic radiation oncology
    • combined treatment and clinical trials
    • summing-up
  • Individual training supplement to head and neck cancer: 1 month (4 weeks) stay on-site